mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function MDA-MB-468 Xenograft Model - Altogen
MDA MB 468 Xenograft Model Altogen Labs Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link MDA MB 468 Luciferase Reporter Cell Line AcceGen Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports Metformin resistant MDA MB 468 cells exhibit EMT like phenotype and increased migration capacity Molecular Biology Reports Springer Nature Link
Pay in 4 interest-free payments of $5.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




